Left ventricular hypertrophy (LVH) is an abnormal thickening of the left ventricular myocardium that occurs as an adaptive mechanism to increased afterload. The left ventricular myocytes hypertrophy ...

Left ventricular hypertrophy (LVH) is a marker of prolonged exposure to high blood pressure and a predictor of cardiovascular disease risk. The objective of the current study was to investigate its ...

WHEN medical terminology was less precise the expression "strained heart" was employed at times to describe obscurely but ominously diseased hearts. This diagnosis is no longer made, but currently the ...

Left ventricular hypertrophy (LVH) is common in patients with cardiovascular disease, in those with cardiovascular risk factors, and in healthy individuals. Although electrocardiography is a ...

May 13, 2009 (San Francisco, California) — Getting blood-pressure levels down to targets recommended in the clinical guidelines regresses left ventricle hypertrophy (LVH) in patients with resistant ...

Myocardial fibrosis is a hallmark of hypertrophic cardiomyopathy and a proposed substrate for arrhythmias and heart failure. In animal models, profibrotic genetic pathways are activated early, before ...

Human neutrophil peptide-1 (HNP-1) is a commonly investigated therapeutic agent. However, its role in hypertensive left ventricular hypertrophy (HLVH) remains unclear. In a new study published in ...

Hypertrophic cardiomyopathy (HCM) affects one in 500 people in the general population. In most cases, HCM is caused by genetic mutations. Doctors usually discover HCM during cardiac testing (an ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...